NO20072245L - Anvendelse av IL-17 til modning av oocytter - Google Patents

Anvendelse av IL-17 til modning av oocytter

Info

Publication number
NO20072245L
NO20072245L NO20072245A NO20072245A NO20072245L NO 20072245 L NO20072245 L NO 20072245L NO 20072245 A NO20072245 A NO 20072245A NO 20072245 A NO20072245 A NO 20072245A NO 20072245 L NO20072245 L NO 20072245L
Authority
NO
Norway
Prior art keywords
mature oocytes
oocytes
vitro
mature
maturation
Prior art date
Application number
NO20072245A
Other languages
English (en)
Inventor
Stephen S Palmer
Ann M Clark
Daniel Gustavo De Matos
Cam Anh T Tran
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35529384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20072245(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20072245L publication Critical patent/NO20072245L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anvendelsen av IL- 17 for in vitio modning av pattedyroocytter er beskrevet. De in vitro modne oocyttene kan anvendes fior in vitro fiertiliseringsprotokoller.
NO20072245A 2004-09-30 2007-04-30 Anvendelse av IL-17 til modning av oocytter NO20072245L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61466704P 2004-09-30 2004-09-30
PCT/US2005/035372 WO2006039592A1 (en) 2004-09-30 2005-09-30 Use of il-17- for maturation of oocytes

Publications (1)

Publication Number Publication Date
NO20072245L true NO20072245L (no) 2007-04-30

Family

ID=35529384

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072245A NO20072245L (no) 2004-09-30 2007-04-30 Anvendelse av IL-17 til modning av oocytter

Country Status (11)

Country Link
US (1) US20070231896A1 (no)
EP (1) EP1794287B1 (no)
JP (1) JP5188806B2 (no)
AT (1) ATE437220T1 (no)
AU (1) AU2005292362B2 (no)
CA (1) CA2578573C (no)
DE (1) DE602005015599D1 (no)
ES (1) ES2329393T3 (no)
IL (2) IL181908A (no)
NO (1) NO20072245L (no)
WO (1) WO2006039592A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110669123B (zh) * 2019-09-03 2020-10-13 南京市妇幼保健院 一种分泌型内源性多肽pdff-co3及其应用
CN113249305A (zh) * 2021-06-04 2021-08-13 华南农业大学 卵母细胞体外成熟培养液添加剂、培养液及其应用
CN113403259B (zh) * 2021-06-04 2023-01-17 华南农业大学 一种提高克隆胚胎发育质量的添加剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169835A (en) * 1989-01-18 1992-12-08 Oklahoma Medical Research Foundation Pregancy specific proteins applications
US20030124092A1 (en) * 2001-06-21 2003-07-03 Eugene Medlock IL-17 like molecules and uses thereoflike molecules and uses thereof
EP1215280A1 (en) * 2000-12-13 2002-06-19 Vrije Universiteit Brussel Method for in vitro culture of ovarian follicles
WO2003076600A2 (en) * 2002-03-08 2003-09-18 Mcgill University In vitro maturation of immature human oocytes
CA2565801A1 (en) * 2004-05-28 2005-12-15 Applied Research Systems Ars Holding N.V. Use of il-17 in the treatment of fertility-related disorders

Also Published As

Publication number Publication date
JP2008514238A (ja) 2008-05-08
WO2006039592A9 (en) 2006-07-27
WO2006039592A1 (en) 2006-04-13
AU2005292362A1 (en) 2006-04-13
IL181908A0 (en) 2007-07-04
ES2329393T3 (es) 2009-11-25
ATE437220T1 (de) 2009-08-15
IL181908A (en) 2010-11-30
US20070231896A1 (en) 2007-10-04
IL206440A0 (en) 2010-12-30
EP1794287A1 (en) 2007-06-13
EP1794287B1 (en) 2009-07-22
DE602005015599D1 (de) 2009-09-03
JP5188806B2 (ja) 2013-04-24
CA2578573C (en) 2015-02-03
AU2005292362B2 (en) 2012-05-31
CA2578573A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
EA201001488A1 (ru) Антиоксидантные модуляторы воспаления: производные олеанолевой кислоты с сатурацией в с-кольце
MY166653A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
MY161991A (en) Proteasome inhibitors
UA115131C2 (uk) Сполуки боронатного ефіру і його фармацевтичні рецептури
RS54266B1 (en) PURINE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC, INFLAMMATORY AND INFECTIVE DISEASES
TW200637614A (en) Bendamustine pharmaceutical compositions
EA200802213A1 (ru) Способы лечения заболеваний крови
EA200802054A1 (ru) Ингибиторы фермента
TW200626558A (en) Indazolone derivatives
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
NO20065859L (no) Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser
NO20072245L (no) Anvendelse av IL-17 til modning av oocytter
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
UY30740A1 (es) Nuevo procedimiento para la preparacion de 4,4??-( 1-metil-1,2-etandilil)-bis-(2,6-piperazindiona)
UY31139A1 (es) Formas cristalinas de 3-(2r-tetrahidrofuril-metil)-2-tioxantina
NO20072159L (no) Anvendelse av graviditetsspesifikt glykoprotein til modning av oocytter
NO20062949L (no) Anvendelse av cytokiner av IL-6-typen for modning av oocytter
ATE435868T1 (de) Homogemcitabine
CY1108048T1 (el) Συνθεση σπογγοσινης
WO2005072274A3 (en) Autoinducer-2 compounds as immunomodulatory agents
ATE540957T1 (de) Bicyclische peptidomimetikum-inhibitoren von aspartylproteasen zur behandlung von infektionskrankheiten
RU2009110875A (ru) Способ прегестационной подготовки женщин с приобретенной и наследственной формами тромбофилии с помощью гирудорефлексотерапии
WO2008111862A3 (en) Methods and compositions for manipulating mammalian embryos
ECSP15032906A (es) COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE DROSPIRENONA Y KIT ANTICONCEPTIVO (DIVISIONAL 2 DE SOLICITUD No. SP-12-12359 PCT)
EA200401037A1 (ru) Антифосфолипазный препарат

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application